Activity Description:

Congenital heart surgery has achieved remarkable advances in anatomic reconstruction, yet some of its greatest remaining challenges cannot be solved by reconstruction alone. Children with complex congenital heart disease - particularly those with single-ventricle physiology - continue to face progressive myocardial dysfunction, limitations of prosthetic materials that cannot grow with the children, and lifelong risks of heart failure and reintervention.

Target Audience: 

This course is designed for Physicians, Advanced Practice Providers, Nurses, and Allied Health Professionals involved in pediatric and adult congenital heart care.

Learning Objectives:

• Describe the evolution of surgical innovation in congenital heart disease
• Examine the translational pathway for regenerative therapies in HLHS
• Explore emerging applications of tissue engineering and regenerative medicine in congenital heart surgery
• Discuss how congenital heart surgeons can serve as surgeon-scientists and clinical innovators 
• Identify the scientific, regulatory, ethical, and implementation challenges

Moderator:

Melody Turner, MSN, MBA, RN, AVP

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and HCA Healthcare. The HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. None of the planners, faculty, and those in control of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.